(AXON) Axon Enterprise - Ratings and Ratios
Taser, Body Cameras, Evidence Software, Cloud Platform
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 59.5% |
| Value at Risk 5%th | 72.6% |
| Relative Tail Risk | -25.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.11 |
| Alpha | -29.51 |
| CAGR/Max DD | 1.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.497 |
| Beta | 1.088 |
| Beta Downside | 1.219 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.34% |
| Mean DD | 8.58% |
| Median DD | 6.48% |
Description: AXON Axon Enterprise September 26, 2025
Axon Enterprise, Inc. (NASDAQ: AXON) designs, manufactures, and sells conducted-energy devices (CEDs) under the TASER brand, alongside a suite of hardware and cloud-based software solutions that enable law-enforcement agencies to capture, store, manage, share, and analyze digital evidence.
The business is organized into two primary segments: (1) TASER, which generates revenue from the sale of CEDs and related accessories (e.g., cartridges, batteries, and extended warranties); and (2) Software & Sensors, which includes body-worn cameras, in-car video systems, and a portfolio of subscription-based evidence-management platforms such as Axon Records, Evidence, and Command.
Axon reaches customers through a mixed-channel model that combines direct sales teams, a network of distribution partners, an online storefront, and third-party resellers; a strategic partnership with Fusus, Inc. expands its capability to aggregate live video, data, and sensor feeds across multiple devices.
The company serves a broad public-safety ecosystem that includes municipal police, federal agencies, corrections, fire and EMS, campus security, private-security firms, and individual consumers seeking personal-safety products.
According to Axon’s FY 2023 earnings release, total revenue reached approximately $1.44 billion, with software-as-a-service (SaaS) subscriptions accounting for roughly 70 % of recurring revenue and growing at a compound annual rate of ~30 % over the prior three years. Gross margins improved to ~71 % driven by the higher-margin SaaS mix, while operating cash flow turned positive in Q4 2023.
Key macro drivers for Axon include municipal budget cycles (which can constrain capital-expenditure on new equipment), the ongoing shift toward digital evidence workflows in law-enforcement agencies, and broader public-policy debates around the use of conducted-energy weapons that can affect adoption rates.
For a deeper, data-driven assessment of Axon’s valuation assumptions and scenario analysis, you may find the research tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (257.1m TTM) > 0 and > 6% of Revenue (6% = 153.5m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -3.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 112.1% (prev 83.11%; Δ 28.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 244.3m <= Net Income 257.1m (YES >=105%, WARN >=100%) |
| Net Debt (678.2m) to EBITDA (310.9m) ratio: 2.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (78.4m) change vs 12m ago 0.43% (target <= -2.0% for YES) |
| Gross Margin 60.31% (prev 59.84%; Δ 0.47pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 47.98% (prev 48.38%; Δ -0.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.52 (EBITDA TTM 310.9m / Interest Expense TTM 67.2m) >= 6 (WARN >= 3) |
Altman Z'' 3.85
| (A) 0.43 = (Total Current Assets 4.22b - Total Current Liabilities 1.35b) / Total Assets 6.66b |
| (B) 0.14 = Retained Earnings (Balance) 933.9m / Total Assets 6.66b |
| (C) 0.04 = EBIT TTM 237.0m / Avg Total Assets 5.33b |
| (D) 0.25 = Book Value of Equity 921.4m / Total Liabilities 3.63b |
| Total Rating: 3.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.00
| 1. Piotroski 3.50pt |
| 2. FCF Yield 0.35% |
| 3. FCF Margin 5.67% |
| 4. Debt/Equity 0.69 |
| 5. Debt/Ebitda 2.18 |
| 6. ROIC - WACC (= -1.45)% |
| 7. RoE 9.66% |
| 8. Rev. Trend 99.55% |
| 9. EPS Trend 90.85% |
What is the price of AXON shares?
Over the past week, the price has changed by +3.48%, over one month by -28.46%, over three months by -30.92% and over the past year by -16.51%.
Is AXON a buy, sell or hold?
- Strong Buy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AXON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 822.5 | 52.3% |
| Analysts Target Price | 822.5 | 52.3% |
| ValueRay Target Price | 642 | 18.9% |
AXON Fundamental Data Overview November 21, 2025
P/E Trailing = 166.4859
P/E Forward = 68.0272
P/S = 16.3836
P/B = 13.9113
P/EG = 2.86
Beta = 1.369
Revenue TTM = 2.56b USD
EBIT TTM = 237.0m USD
EBITDA TTM = 310.9m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 279.6m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.2m USD (from netDebt column, last quarter)
Enterprise Value = 41.63b USD (41.91b + Debt 2.10b - CCE 2.38b)
Interest Coverage Ratio = 3.52 (Ebit TTM 237.0m / Interest Expense TTM 67.2m)
FCF Yield = 0.35% (FCF TTM 145.0m / Enterprise Value 41.63b)
FCF Margin = 5.67% (FCF TTM 145.0m / Revenue TTM 2.56b)
Net Margin = 10.05% (Net Income TTM 257.1m / Revenue TTM 2.56b)
Gross Margin = 60.31% ((Revenue TTM 2.56b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 60.14% (prev 60.39%)
Tobins Q-Ratio = 6.25 (Enterprise Value 41.63b / Total Assets 6.66b)
Interest Expense / Debt = 1.38% (Interest Expense 28.9m / Debt 2.10b)
Taxrate = 113.9% (out of range, set to none) (17.9m / 15.7m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.12 (Total Current Assets 4.22b / Total Current Liabilities 1.35b)
Debt / Equity = 0.69 (Debt 2.10b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 2.18 (Net Debt 678.2m / EBITDA 310.9m)
Debt / FCF = 4.68 (Net Debt 678.2m / FCF TTM 145.0m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 257.1m / Total Assets 6.66b)
RoE = 9.66% (Net Income TTM 257.1m / Total Stockholder Equity 2.66b)
RoCE = 5.40% (EBIT 237.0m / Capital Employed (Equity 2.66b + L.T.Debt 1.73b))
RoIC = 8.09% (EBIT 237.0m / (Assets 6.66b - Curr.Liab 1.35b - Cash 2.38b))
WACC = 9.54% (E(41.91b)/V(44.01b) * Re(10.02%) + (debt cost/tax rate unavailable))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.46%
[DCF Debug] Terminal Value 75.29% ; FCFE base≈175.1m ; Y1≈216.0m ; Y5≈368.5m
Fair Price DCF = 56.45 (DCF Value 4.45b / Shares Outstanding 78.9m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 90.85 | EPS CAGR: 28.27% | SUE: -1.68 | # QB: 0
Revenue Correlation: 99.55 | Revenue CAGR: 37.11% | SUE: 0.83 | # QB: 0
Additional Sources for AXON Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle